Luke is a 4th-year MD-PhD candidate at Johns Hopkins, currently pursuing a PhD in Biomedical Engineering. He previously earned a B.S. in Chemical & Biomolecular Engineering from Georgia Tech. Luke's research leverages protein engineering techniques to develop antibody/cytokine fusion proteins for targeted activation or regulation of the immune system. Long-term, he hopes to become an abdominal transplant surgeon and work to develop new immunosuppressive therapies for organ transplant recipients.

‍

What is a healthcare advancement you hope to see in your lifetime?

Dismissed as a distant dream, it was previously said that: xenotransplantation is the future and always will be. But I believe that in the coming decades, pig-to-human xenotransplantation will finally become a clinical reality and expand the supply of donor organs for individuals with end-stage organ disease.

‍

What excites you most about working with ARTIS?

I'm excited to collaborate with and learn from the talented partners, analysts, and fellows at ARTIS. I also look forward to gaining more insight into how an invention in the lab is translated into a viable therapeutic that reaches patients.

‍

What is your greatest accomplishment?

Finishing an Ironman triathlon and, more importantly, completing a two-foot-long burrito eating challenge afterwards.